Skip to search.
 FTSE 100 Down 2.44%

More On OXB.L

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Oxford BioMedica PLC (OXB.L)

-LSE Ticker: 664815/ISIN: GB0006648157
7.50 Down 0.38(4.82%) 4 Sep 16:35
Add to Portfolio
Prev Close:7.88
Open:7.99
Bid:7.49
Ask:7.51
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:7.50 - 8.23
52wk Range:3.59 - 13.38
Volume:231,889
Avg Vol (3m):3,474,400
Market Cap:192.58m
P/E (ttm):N/A
EPS (ttm):-0.00
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in GBp.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,524.28
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.32
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oxford BioMedica plc, a biopharmaceutical company, develops gene-based medicines and therapeutic vaccines. Its LentiVector platform technology integrates genes into non-dividing cells in the brain and the eye, as well as accommodates multiple ther... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback